Fu‐Pang Chang

Later Onset Fabry Disease, Cardiac Damage Progress in Silence

Ting‐Rong Hsu, Sheng‐Che Hung, Fu‐Pang Chang et al. · Journal of the American College of Cardiology · 2016 · 108 citations

Medicine, Cardiology, Neurology +12

Clinical and genetic profiles of hereditary transthyretin amyloidosis in Taiwan

Hua‐Chuan Chao, Yi‐Chu Liao, Yo‐Tsen Liu et al. · Annals of Clinical and Translational Neurology · 2019 · 44 citations · Full text

Life Sciences, Genetics, Neurology +15

GGC Repeat Expansion of <i>NOTCH2NLC</i> in Taiwanese Patients With Inherited Neuropathies

Yi‐Chu Liao, Fu‐Pang Chang, Han-Wei Huang et al. · Neurology · 2021 · 43 citations

Medicine, Genetics, Neurology +16

Globotriaosylsphingosine (lyso-Gb3) might not be a reliable marker for monitoring the long-term therapeutic outcomes of enzyme replacement therapy for late-onset Fabry patients with the Chinese hotspot mutation (IVS4+919G&gt;A)

Haochuan Liu, Hsiang-Yu Lin, Chia‐Feng Yang et al. · Orphanet Journal of Rare Diseases · 2014 · 38 citations · Full text

Life Sciences, Cardiology, Genetics +14

Identification of Galectin-3 as Potential Biomarkers for Renal Fibrosis by RNA-Sequencing and Clinicopathologic Findings of Kidney Biopsy

Shuo‐Ming Ou, Ming‐Tsun Tsai, Huan‐Yuan Chen et al. · Frontiers in Medicine · 2021 · 38 citations · Full text

Medicine, Nephrology, Pathology +17